Bristol-Myers Squibb Co (Bristol-Myers Squibb Co) Ending Cash Position : $9,334.00 Mil (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Bristol-Myers Squibb Co Ending Cash Position?

Bristol-Myers Squibb Co's Ending Cash Position for the quarter that ended in Mar. 2024 was $9,334.00 Mil.

Bristol-Myers Squibb Co's quarterly Ending Cash Position increased from Sep. 2023 ($7,568.00 Mil) to Dec. 2023 ($11,519.00 Mil) but then declined from Dec. 2023 ($11,519.00 Mil) to Mar. 2024 ($9,334.00 Mil).

Bristol-Myers Squibb Co's annual Ending Cash Position declined from Dec. 2021 ($14,316.00 Mil) to Dec. 2022 ($9,325.00 Mil) but then increased from Dec. 2022 ($9,325.00 Mil) to Dec. 2023 ($11,519.00 Mil).

Bristol-Myers Squibb Co Ending Cash Position Historical Data

The historical data trend for Bristol-Myers Squibb Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bristol-Myers Squibb Co Ending Cash Position Chart

Bristol-Myers Squibb Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

12,820.00

14,973.00

14,316.00

9,325.00

11,519.00

Bristol-Myers Squibb Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															9,048.00	8,425.00	7,568.00	11,519.00	9,334.00

Bristol-Myers Squibb Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Bristol-Myers Squibb Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	9325	+	2194
	=	11,519.00

Bristol-Myers Squibb Co's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	11519	+	-2185
	=	9,334.00

Bristol-Myers Squibb Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Bristol-Myers Squibb Co (Bristol-Myers Squibb Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (OTCPK:BMYMP.PFD) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

BMY:USA BMY:Peru BMY:Mexico 1BMY:Italy BRMd:UK 0R1F:UK BRM:Germany BMYB34:Brazil BMYS:Austria BMY:Argentina

Address

430 East 29th Street, 14th Floor, New York, NY, USA, 10016

Website

https://www.bms.com

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.